These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20534389)

  • 1. [Bladder cancer and new drugs].
    Massard C; Albouy B; Gross-Goupil M; Ravaud A
    Bull Cancer; 2010; 97 Suppl Cancer de la vessie():43-50. PubMed ID: 20534389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D; Pectasides M; Economopoulos T
    Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
    Lehmann J; Retz M; Stöckle M
    World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of bladder cancer trials in the European Organization for Research and Treatment.
    de Wit R;
    Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced bladder cancer.
    Roth BJ
    Semin Oncol; 1996 Oct; 23(5):633-44. PubMed ID: 8893874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving role of chemotherapy in advanced urothelial cancer.
    Calabrò F; Sternberg CN
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy practices and perspectives in invasive bladder cancer.
    Flechon A; Droz JP
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1473-82. PubMed ID: 17069531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
    Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy options for metastatic bladder cancer.
    Siefker-Radtke A
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):877-85. PubMed ID: 16761931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative chemotherapy for bladder cancer.
    Sonpavde G; Petrylak DP
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):133-44. PubMed ID: 15990329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of invasive bladder cancer].
    Kotake T
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review and outlook for the role of paclitaxel in urothelial carcinoma.
    Vaughn DJ
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel in the treatment of advanced urothelial cancer.
    Bajorin DF
    Oncology (Williston Park); 2000 Jan; 14(1):43-52, 57; discussion 58, 61-2. PubMed ID: 10680149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why use chemotherapy in cancer of the bladder? What are the initial limitations].
    Maraninchi D; Viens P
    Ann Urol (Paris); 1994; 28(6-7):334-7. PubMed ID: 7534457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Place of chemotherapy in the treatment of invasive bladder tumors].
    Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
    Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.